Common drug could aid reversal of optic neuropathy in Multiple Sclerosis patients

Written by Alice Weatherston

A common antihistamine, termed clemastine fumarate, may help to reverse chronic vision damage in individuals with Multiple Sclerosis (MS), a new finding presented at the American Academy of Neurology 68th Annual Meeting (15 – 21st April 2016, Vancouver, Canada) has revealed. “This study is exciting because it is the first to demonstrate possible repair of that protective coating in people with chronic demyelination from MS,” commented study author Ari Green (University of California San Francisco, USA). The study was carried out over a 5 month period and included 50 individuals with MS. Participants were on average 40 years of age...

To view this content, please register now for access

It's completely free